Knowledge Exchange by ISID

Sign in to view your progression
Program Overview Progr...
Learning Objectives Learn...
Target Audience Targe...
References Refer...
Disclosure/Disclaimer Discl...

Activity Title: Global Dengue Outbreak Preparedness
Release Date: February 15, 2022
Estimated Time to Complete Activity: 70 minutes

Statement of Need:
The number of people affected by mosquito-borne diseases is rapidly growing. In recent years, population growth, climate change, increase in international travel, and the movement of people from rural areas to cities have all increased the spread of Aedes aegypti mosquitoes. According to the World Health Organization, the global incidence of dengue has grown dramatically in recent decades. Currently, about half of the world's population is at risk for dengue and recent studies estimate that up to 90% of the global population could be at risk by the end of this century. The predicted expansion of vectors towards higher altitudes and temperate regions suggests that dengue outbreaks will occur in areas where people might be immunologically naive and public health systems unprepared. During this session, experts will discuss new modeling studies that forecast the global distribution of Aedes aegypti and the drivers of the expanded reach such as climate change and urbanization. They will discuss updates in the clinical management of dengue outbreaks and highlight recent innovations in vector control strategies such as the deployment of Wolbachia-carrying mosquitoes.

Faculty:
Associate professor Rachel Lowe - Royal Society Dorothy Hodgkin Fellow, UK
Professor Cameron Simmons - Monash University, Australia
Professor Lucy Lum - University  of Malaysia

Technical Requirements
This site and its activities are best viewed using the latest versions of Chrome, Edge, Firefox, and Safari browsers. For interactive content, a broadband connection is required. For CME/CE activities featuring audio, you need a sound card and speakers.
Our activities may require JavaScript to be enabled on your computer. If you are having difficulty viewing pop-up windows, click here for instructions on enabling JavaScript.
Contact Information
If you have questions about this CME activity, please contact The International Society for Infectious Diseases at  info@isid.org.

For technical support issues, please contact Multilearning at support@multilearning.com

Upon completion of this module, participants will be able to:

  • Understand the growing number of people affected by mosquito-borne diseases, and the reasons for this growth.
  • Discuss new modeling studies that forecast the global distribution of Aedes aegypti and the drivers of the expanded reach
  • Discuss updates in the clinical management of dengue outbreaks
  • Discuss recent innovations in vector control strategies such as the deployment of Wolbachia-carrying mosquitoes.

 

Upon completion of this module, participants should be able to:

World Health Organization (WHO): Handbook for clinical management of dengue (2012)

WHO: Dengue guidelines for diagnosis, treatment, prevention, and control (2009)

National Vector Borne Disease Control Programme (NVBDCP): National guidelines for clinical management of dengue (India, 2014)

American Academy of Pediatrics (AAP): Red Book – Dengue (2021)

Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue.Utarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, Supriyati E, Wardana DS, Meitika Y, Ernesia I, Nurhayati I, Prabowo E, Andari B, Green BR, Hodgson L, Cutcher Z, Rancès E, Ryan PA, O'Neill SL, Dufault SM, Tanamas SK, Jewell NP, Anders KL, Simmons CP, AWED Study Group 

N Engl J Med. 2021;384(23):2177. 

https://pubmed.ncbi.nlm.nih.gov/34107180/

Disclosure Policy

In accordance with the EACCME Standards for Commercial Support, the International Society for Infectious Diseases (ISID) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ISID  resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all our educational programs. Furthermore, ISID seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ISID is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures:

The planners, reviewers, editors, staff, or other members at the International Society for Infectious Diseases who control content have no relevant financial relationships to disclose. 

ISID Knowledge Exchange and E-Learning Platform Organizing Committee members are listed here along with Committee members’ disclosure forms. 

Faculty Disclosures:

Rachel Lowe has no actual or potential conflict of interest in relation to this program/presentation

Cameron Simmons has no actual or potential conflict of interest in relation to this program/presentation

Lucy Lum :
Receipt of grants/research supports: Sysmex Asia Pacific
Receipt of honoraria or consultation fees: B Braun, Roche Diagnostics

Moderator Disclosures:
Athanase Badolo has no actual or potential conflict of interest in relation to this program/presentation
Veasna Duong has no actual or potential conflict of interest in relation to this program/presentation

Disclosure of Unlabeled Use

The International Society for Infectious Diseases  requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ISID does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The International Society for Infectious Diseases presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The International Society for Infectious Diseases, and the former commercial supporter assume no liability for the information herein.

Copyright Information

Copyright © 2021 by the International Society for Infectious Diseases. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

•  The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

•  Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without the International Society for Infectious Diseases' prior written permission.

Privacy Policy

The International Society for Infectious Diseases protects the privacy of personal and other information regarding participants and educational collaborators. The International Society for Infectious Diseases will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The International Society for Infectious Diseases maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding the International Society for Infectious Diseases Privacy Policy and ISID’s Knowledge Exchange and E-Learning Platform Privacy Policy can be viewed at https://isid.org/privacy-policy/ and https://exchange.isid.org/isid/legal/terms-and-conditions.

LIVE SESSION
Global Dengue Outbreak Preparedness

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies